Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2019

01-08-2019 | Research Article

Perceptions of medicine use among pregnant women: an interview-based study

Authors: Rasmus Søgaard Nyholm, Jon Trærup Andersen, Charlotte Vermehren, Susanne Kaae

Published in: International Journal of Clinical Pharmacy | Issue 4/2019

Login to get access

Abstract

Background When women are in a condition that requires medicines during pregnancy they have to balance the health benefits of the medical treatment against the potential risk of harming their unborn child. Too high teratogenic risk perceptions among pregnant women can lead them to stop taking the medicine, worsening the symptoms for the mother and even harming their foetus. Many women today who use over-the-counter and prescribed medicines have been shown to change their medical behaviour when they become pregnant. Objective To explore in depth the perceptions of medication use among women during their pregnancy. Setting The Capital Region of Denmark. Methods Participants were recruited from social network groups on Facebook and from participants in lectures and antenatal classes for pregnant women in two hospitals. Two focus groups interviews and three individual semi-structured interviews were conducted. The interview guides were based on existing literature and relatively unstructured, with an emphasis on open-ended questions. Interview transcripts were analysed using the phenomenological approach of meaning condensation. Main Outcome measure Pregnant women’s’ perceptions of medicine including aspects related to their safety feeling of medicines and perceived support from health care professionals. Results The women believed that it is less safe to take medicines during pregnancy, largely due to the risk of the child getting a disease in the future, but also due to the risk of malformation. Lack of clinical tests and uncertainty about how the unborn child reacts to medications were reported causes of these concerns. Most participants were concerned about using medicines and avoided them if possible, including over-the counter medicines. Conversations with physicians had a calming effect although the physicians appeared to be unclear in their guidance regarding dietary supplements. Some women received conflicting information on the Internet. Several suggestions were made about how to reduce uncertainties about the safety of taking medicines during pregnancy. Conclusion Many pregnant women are concerned about how to use medicines. To reduce these concerns and ensure the appropriate use of medicines during pregnancy, initiatives are needed to strengthen evidence-based advice from health care professionals, especially during the first trimester.
Literature
1.
go back to reference Zaki NM, Albarraq AA. Use, attitudes and knowledge of medications among pregnant women: a Saudi study. Saudi Pharm J. 2014;22(5):419–28.CrossRefPubMed Zaki NM, Albarraq AA. Use, attitudes and knowledge of medications among pregnant women: a Saudi study. Saudi Pharm J. 2014;22(5):419–28.CrossRefPubMed
2.
go back to reference Twigg MJ, Lupattelli A, Nordeng H. Women’s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968–76.CrossRefPubMedPubMedCentral Twigg MJ, Lupattelli A, Nordeng H. Women’s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968–76.CrossRefPubMedPubMedCentral
3.
go back to reference Nordeng H, Koren G, Einarson A. Pregnant women’s beliefs about medications—a study among 866 Norwegian women. Ann Pharmacother. 2010;44(9):1478–84.CrossRefPubMed Nordeng H, Koren G, Einarson A. Pregnant women’s beliefs about medications—a study among 866 Norwegian women. Ann Pharmacother. 2010;44(9):1478–84.CrossRefPubMed
4.
go back to reference Mulder B, Bijlsma MJ, Schuiling-Veninga CC, Morssink LP, van Puijenbroek E, Aarnoudse JG, et al. Risks versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adher. 2018;12:1–8. Mulder B, Bijlsma MJ, Schuiling-Veninga CC, Morssink LP, van Puijenbroek E, Aarnoudse JG, et al. Risks versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adher. 2018;12:1–8.
5.
go back to reference Csajka C, Jaquet A, Winterfeld U, Meyer Y, Einarson A, Panchaud A. Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey. Swiss Med Wkly. 2014;144:w13936.PubMed Csajka C, Jaquet A, Winterfeld U, Meyer Y, Einarson A, Panchaud A. Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey. Swiss Med Wkly. 2014;144:w13936.PubMed
6.
go back to reference Widnes SF, Schjott J, Eide GE, Granas AG. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug Saf. 2013;36(6):481–9.CrossRefPubMed Widnes SF, Schjott J, Eide GE, Granas AG. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug Saf. 2013;36(6):481–9.CrossRefPubMed
7.
go back to reference Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1–176.CrossRefPubMedPubMedCentral Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1–176.CrossRefPubMedPubMedCentral
8.
go back to reference Petersen I, McCrea RL, Osborn DJ, Evans S, Pinfold V, Cowen PJ, et al. Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res. 2014;159(1):218–25.CrossRefPubMed Petersen I, McCrea RL, Osborn DJ, Evans S, Pinfold V, Cowen PJ, et al. Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res. 2014;159(1):218–25.CrossRefPubMed
9.
go back to reference Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011;72(7):979–85.CrossRefPubMed Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011;72(7):979–85.CrossRefPubMed
10.
go back to reference Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Int J Clin Pharm. 2014;36(1):145–53.CrossRefPubMed Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Int J Clin Pharm. 2014;36(1):145–53.CrossRefPubMed
11.
go back to reference Koren G. The way women perceive teratogenic risk. Can J Clin Pharmacol. 2007;14(1):e10–6.PubMed Koren G. The way women perceive teratogenic risk. Can J Clin Pharmacol. 2007;14(1):e10–6.PubMed
12.
go back to reference Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154–66.CrossRefPubMed Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154–66.CrossRefPubMed
15.
go back to reference Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14.CrossRefPubMed Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14.CrossRefPubMed
16.
go back to reference Petersen I, McCrea RL, Lupattelli A, Nordeng H. Women’s perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey. BMJ Open. 2015;5(6):e007390.CrossRefPubMedPubMedCentral Petersen I, McCrea RL, Lupattelli A, Nordeng H. Women’s perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey. BMJ Open. 2015;5(6):e007390.CrossRefPubMedPubMedCentral
17.
go back to reference Widnes SF, Schjott J. Risk perception regarding drug use in pregnancy. Am J Obstet Gynecol. 2017;216(4):375–8.CrossRefPubMed Widnes SF, Schjott J. Risk perception regarding drug use in pregnancy. Am J Obstet Gynecol. 2017;216(4):375–8.CrossRefPubMed
18.
go back to reference Sanz E, Gomez-Lopez T, Martinez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):127–31.CrossRefPubMed Sanz E, Gomez-Lopez T, Martinez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):127–31.CrossRefPubMed
19.
go back to reference Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed
20.
go back to reference Kaae S, Traulsen J. Qualitative methods in pharmacy practice research. In: Babar ZUD, editor. Pharmacy practice research methods. Adis/Springer: Cham; 2015. p. 49–68. Kaae S, Traulsen J. Qualitative methods in pharmacy practice research. In: Babar ZUD, editor. Pharmacy practice research methods. Adis/Springer: Cham; 2015. p. 49–68.
22.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRef Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRef
23.
go back to reference Kvale S. Methods of analysis. In: Kvale S, editor. Interviews. An introduction to qualitative research interviewing. Thousand Oaks: SAGE Publications; 1996. p. 187–209. Kvale S. Methods of analysis. In: Kvale S, editor. Interviews. An introduction to qualitative research interviewing. Thousand Oaks: SAGE Publications; 1996. p. 187–209.
24.
go back to reference Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res Part C Embryo Today Rev. 2015;105(2):140–56.CrossRef Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res Part C Embryo Today Rev. 2015;105(2):140–56.CrossRef
26.
go back to reference McDonald K, Amir LH, Davey MA. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011;11(Suppl 5):S5.CrossRefPubMedPubMedCentral McDonald K, Amir LH, Davey MA. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011;11(Suppl 5):S5.CrossRefPubMedPubMedCentral
27.
go back to reference Hippman C, Balneaves LG. Women’s decision making about antidepressant use during pregnancy: a narrative review. Depress Anxiety. 2018;35(12):1158–67.CrossRefPubMed Hippman C, Balneaves LG. Women’s decision making about antidepressant use during pregnancy: a narrative review. Depress Anxiety. 2018;35(12):1158–67.CrossRefPubMed
28.
go back to reference Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66(7):657–64.CrossRefPubMed Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66(7):657–64.CrossRefPubMed
29.
go back to reference Koren G, Pastuszak A. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology. 1990;41(6):657–61.CrossRefPubMed Koren G, Pastuszak A. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology. 1990;41(6):657–61.CrossRefPubMed
30.
go back to reference Devkota R, Khan GM, Alam K, Sapkota B, Devkota D. Impacts of counseling on knowledge, attitude and practice of medication use during pregnancy. BMC Pregnancy Childbirth. 2017;17(1):131.CrossRefPubMedPubMedCentral Devkota R, Khan GM, Alam K, Sapkota B, Devkota D. Impacts of counseling on knowledge, attitude and practice of medication use during pregnancy. BMC Pregnancy Childbirth. 2017;17(1):131.CrossRefPubMedPubMedCentral
31.
go back to reference Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB. Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety. Prim Care Companion CNS Disord. 2011;13(2), https://doi.org/10.4088/PCC.10m01028. Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB. Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety. Prim Care Companion CNS Disord. 2011;13(2), https://​doi.​org/​10.​4088/​PCC.​10m01028.
32.
go back to reference Gils C, Pottegard A, Ennis ZN, Damkier P. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey. BMC Pregnancy Childbirth. 2016;16:226.CrossRefPubMedPubMedCentral Gils C, Pottegard A, Ennis ZN, Damkier P. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey. BMC Pregnancy Childbirth. 2016;16:226.CrossRefPubMedPubMedCentral
33.
go back to reference Baron R, Heesterbeek Q, Mannien J, Hutton EK, Brug J, Westerman MJ. Exploring health education with midwives, as perceived by pregnant women in primary care: a qualitative study in the Netherlands. Midwifery. 2017;46:37–44.CrossRefPubMed Baron R, Heesterbeek Q, Mannien J, Hutton EK, Brug J, Westerman MJ. Exploring health education with midwives, as perceived by pregnant women in primary care: a qualitative study in the Netherlands. Midwifery. 2017;46:37–44.CrossRefPubMed
34.
go back to reference McLaughlin K, Kable A, Ebert L, Murphy V. Midwives’ perception of their role in providing antenatal asthma management in Australia—a qualitative study. Midwifery. 2016;35:11–6.CrossRefPubMed McLaughlin K, Kable A, Ebert L, Murphy V. Midwives’ perception of their role in providing antenatal asthma management in Australia—a qualitative study. Midwifery. 2016;35:11–6.CrossRefPubMed
35.
go back to reference Warriner S, Bryan K, Brown AM. Women’s attitude towards the use of complementary and alternative medicines (CAM) in pregnancy. Midwifery. 2014;30(1):138–43.CrossRefPubMed Warriner S, Bryan K, Brown AM. Women’s attitude towards the use of complementary and alternative medicines (CAM) in pregnancy. Midwifery. 2014;30(1):138–43.CrossRefPubMed
36.
go back to reference Sinclair M, Lagan BM, Dolk H, McCullough JEM. An assessment of pregnant women’s knowledge and use of the Internet for medication safety information and purchase. J Adv Nurs. 2018;74(1):137–47.CrossRefPubMed Sinclair M, Lagan BM, Dolk H, McCullough JEM. An assessment of pregnant women’s knowledge and use of the Internet for medication safety information and purchase. J Adv Nurs. 2018;74(1):137–47.CrossRefPubMed
37.
go back to reference De Santis M, De Luca C, Quattrocchi T, Visconti D, Cesari E, Mappa I, et al. Use of the Internet by women seeking information about potentially teratogenic agents. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):154–7.CrossRefPubMed De Santis M, De Luca C, Quattrocchi T, Visconti D, Cesari E, Mappa I, et al. Use of the Internet by women seeking information about potentially teratogenic agents. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):154–7.CrossRefPubMed
38.
go back to reference Peters SL, Lind JN, Humphrey JR, Friedman JM, Honein MA, Tassinari MS, et al. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiol Drug Saf. 2013;22(3):324–8.CrossRefPubMed Peters SL, Lind JN, Humphrey JR, Friedman JM, Honein MA, Tassinari MS, et al. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiol Drug Saf. 2013;22(3):324–8.CrossRefPubMed
39.
go back to reference Koren G, Bozzo P. Cost effectiveness of teratology counseling—the Motherisk experience. J Popul Ther Clin Pharmacol. 2014;21(2):e266–70.PubMed Koren G, Bozzo P. Cost effectiveness of teratology counseling—the Motherisk experience. J Popul Ther Clin Pharmacol. 2014;21(2):e266–70.PubMed
Metadata
Title
Perceptions of medicine use among pregnant women: an interview-based study
Authors
Rasmus Søgaard Nyholm
Jon Trærup Andersen
Charlotte Vermehren
Susanne Kaae
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00840-4

Other articles of this Issue 4/2019

International Journal of Clinical Pharmacy 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.